Pace and ablate for atrial fibrillation
Part of Heart & circulation clinical trials.
This study looks at how well a treatment called 'pace and ablate' works for people with atrial fibrillation. It involves using a pacemaker or similar device to control the heart rate, and it aims to see who benefits most and how they do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation.
- You are having a procedure called AV node ablation, which helps control your heart rate, and you already have or will get a pacemaker or similar device.
- You have had an echocardiogram (heart ultrasound) to check your heart's pumping function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of heart pacing and a specialized ablation procedure in older adults with permanent atrial fibrillation that hasn't improved with other treatments. It aims to improve symptoms and reduce hospital stays related to heart failure.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This trial tests a special way to pace the heart and a procedure to quiet the irregular rhythm in people with advanced heart failure and long-standing atrial fibrillation. It may help improve symptoms and heart function, possibly reducing the need for a transplant.
This study compares two treatments for people with atrial fibrillation and heart failure: one is a procedure to fix the irregular heartbeat (AF ablation), and the other involves a different type of pacing for the heart. It aims to find which approach helps you feel better and stay out of the hospital.
This study compares two procedures for people who have both atrial fibrillation (AFib) and heart failure: one that slows the heart's electrical signals (AV node ablation) and one that helps the heart pump in a more coordinated way (cardiac resynchronization). Both are options when medications alone aren't enough, and the goal is to improve symptoms and quality of life.
This trial compares two types of pacing for people with permanent atrial fibrillation (AF) and a weak heart pump (ejection fraction less than 50%). It tests whether pacing the left bundle branch area works as well as or better than standard biventricular pacing to improve heart function.
Hear when a new Pacing-Induced Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.